Samsung broadens medical device strategy with Accuray collaboration
Samsung Electronics’ Medical Device Business Division and Samsung Medison said they are expanding partnerships beyond diagnostic imaging. They signed a non-binding LOI with U.S. radiosurgery specialist Accuray to explore integrating Samsung’s mobile CT (BodyTom) with Accuray’s CyberKnife for volumetric imaging-based precision radiation therapy. Samsung also referenced an expanded collaboration with HistoSonics.
How this was made
The 30-second read
Why it matters
The article’s incremental value is the new Accuray LOI to explore integrating Samsung’s BodyTom mobile CT with Accuray’s CyberKnife for volumetric imaging-based precision radiation therapy.
Market read
A non-binding LOI outlines a potential platform integration in image-guided radiosurgery, with a near-term catalyst being an ASTRO Annual Meeting presentation.
What to watch
Key execution details are missing, including integration timelines, reimbursement/clinical workflow fit, and whether Samsung’s imaging platform is already compatible with CyberKnife operational requirements.
Background
Samsung is expanding beyond diagnostic imaging into precision therapy, following an earlier ultrasound cancer therapy collaboration with HistoSonics.
Market effects
Highlights competitive pressure in image-guided radiation therapy, where integrated imaging and robotic delivery can differentiate platforms.
Could modestly influence sentiment around Korean med-tech hardware strategy, but without binding financial terms impact is likely muted.
US-based Accuray collaboration signals cross-border platform integration efforts in radiation oncology technology.
Counterpoint
Because the LOI is non-binding, the market may discount it until there is a signed commercial agreement, regulatory pathway clarity, or measurable clinical adoption.
Key entities
- companySamsung Electronics Medical Device Business Division
Announced expansion of strategic partnerships into radiation therapy via a new LOI with Accuray.
- companySamsung Medison
Co-announced the Accuray LOI and the planned integration of BodyTom with CyberKnife.
- companyAccuray
Radiosurgery specialist partnering with Samsung to explore volumetric imaging-based precision radiation therapy solutions.
- companyHistoSonics
Earlier ultrasound cancer therapy collaboration referenced as part of Samsung’s broader move into therapy.
